Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics

No Pathway Network information available for Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics

Pathways in the Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Obsessive-compulsive disorderEnrichmentHTR2A, SLC6A45.39
2Auriculocondylar syndrome 1EnrichmentGNAI3, PLCB44.61
3Major depressive disorderEnrichmentHTR2A, TPH24.39
4Melanoma, uvealEnrichmentGNAQ, PLCB44.21
5Pseudohypoparathyroidism, type icEnrichmentGNAS2.69
6Osseous heteroplasia, progressiveEnrichmentGNAS2.69
7Deafness, autosomal recessive 44EnrichmentADCY12.69
8Sturge-weber syndromeEnrichmentGNAQ2.69
9Ventricular tachycardia, familialEnrichmentGNAI22.69
10Acth-independent macronodular adrenal hyperplasia 1EnrichmentGNAS2.69
11Spondylometaphyseal dysplasia with corneal dystrophyEnrichmentPLCB32.69
12Pituitary adenoma 3, multiple typesEnrichmentGNAS2.69
13Auriculocondylar syndrome 2aEnrichmentPLCB42.69
14Brunner syndromeEnrichmentMAOA2.69
15Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalitiesEnrichmentGNAI12.69
16Periodic fever, menstrual cycle-dependentEnrichmentHTR1A2.69
17Disorders of gnas inactivationEnrichmentGNAS2.69
18Auriculocondylar syndrome 2bEnrichmentPLCB42.69
19Monostotic fibrous dysplasiaEnrichmentGNAS2.69
20Mazabraud syndromeEnrichmentGNAS2.69
21Pseudohypoparathyroidism, type iaEnrichmentGNAS2.38
22Major affective disorder 1EnrichmentTPH22.38
23Pituitary adenoma 4, acth-secretingEnrichmentGNAI22.38
24Pigmented nodular adrenocortical disease, primary, 1EnrichmentGNAS2.38
25PseudopseudohypoparathyroidismEnrichmentGNAS2.38
26Aromatic l-amino acid decarboxylase deficiencyEnrichmentDDC2.38
27Parkinsonism-dystonia 2, infantile-onsetEnrichmentSLC18A22.38
28PseudohypoparathyroidismEnrichmentGNAS2.38
29Ocular melanomaEnrichmentPLCB42.38
30HypopituitarismEnrichmentGNAI22.38
31Acth-independent macronodular adrenal hyperplasiaEnrichmentGNAS2.38
32Phakomatosis cesioflammeaEnrichmentGNAQ2.38
33Mccune-albright syndromeEnrichmentGNAS2.21
34Cushing syndrome due to bilateral macronodular adrenocortical diseaseEnrichmentGNAS2.21
35Anastomosing haemangiomaEnrichmentGNAQ2.21
36Pseudohypoparathyroidism, type ibEnrichmentGNAS2.08
37Developmental and epileptic encephalopathy 12EnrichmentPLCB12.08
38Achromatopsia 4EnrichmentGNAI32.08
39Capillary malformations, congenitalEnrichmentGNAQ1.99
40Klippel-trenaunay-weber syndromeEnrichmentGNAQ1.91
41AnxietyEnrichmentSLC6A41.91
42BrachydactylyEnrichmentGNAS1.84
43Spastic paraplegia 4, autosomal dominantEnrichmentGNAS1.79
44Developmental and epileptic encephalopathy 14EnrichmentPLCB11.73
45Primary hyperaldosteronismEnrichmentGNAS1.73
46RasopathyEnrichmentDDC1.28
47Benign epilepsy with centrotemporal spikesEnrichmentPLCB11.09
48Centralopathic epilepsyEnrichmentPLCB11.07
49West syndromeEnrichmentPLCB11.06
50Body mass index quantitative trait locus 11EnrichmentGNAS1.01
51SchizophreniaEnrichmentHTR2A0.94
52Rare autosomal recessive non-syndromic sensorineural deafness type dfnbEnrichmentADCY10.77

Loading...
Loading...
Loading...